Follow Us
© 2026 Arizent. All rights reserved.
The demand for weight loss drugs has skyrocketed over the past several years, but GLP1-s alone won’t lead to long-term, holistic health changes for employees.
GLP-1 use for overweight and obesity conditions has increased 587% over the past five years, according to a study by FAIR Health, and data from the International Foundation of Employee Benefit Plans shows the drugs now account for 10.5% of total annual employer claims.
Lee joined the EBN team in 2022, and covers areas including caregiving, employee health and wellness, healthcare innovation, and company culture. She created EBN's popular Benefits in Action and … Read full bio
For reprint and licensing requests for this article, click here.
Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
Kelley Daviss brought in Twin Health and heard great things from employees — then an unexpected diagnosis led her to experience the metabolic health platform's impact herself.
The potential for a healthier lifestyle is extending beyond medication to lifestyle and workplace habits that create change for employees.
Multiple experts weigh in on the challenges and considerations benefit leaders need to keep in mind as they make decisions about medication coverage.
